Women with sickle cell disease who undergo a stem cell transplant can become pregnant and give birth to healthy children,…
Articles by Marisa Wexler, MS
TALEN, a gene-editing technology being used by the clinical-stage biopharmaceutical company Cellectis to develop potentially life-changing therapies, was able…
Treatment with the gene-editing therapy Casgevy (exagamglogene autotemcel) substantially decreased the rates of painful vaso-occlusive crises (VOCs) among…
England’s National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending the country’s National Health Service…
A nurse clinician-scientist and professor at the University of Toronto, in Canada, is being honored for her work in developing…
The American Red Cross and the Sickle Cell Disease Association of Illinois (SCDAI) recently joined a national distributor of propane,…
Bluebird Bio has struck a deal with Medicaid in the state of Michigan to allow eligible people with…
Starting in 2025, the U.S. Department of Health and Human Services (HHS) will introduce a pricing model that aims to…
England’s National Health Service (NHS) is introducing a new genetic test that seeks to make it safer for people with…
Comer Children’s Hospital at the University of Chicago will be one of the first centers in the U.S.